Hematology/Oncology News

Three women oncologist researchers at Dana Farber Cancer Institute have been named recipients of the Damon Runyon Cancer Research Foundation Clinical Investigator Award.

The COVID-19 pandemic had a great impact on the health care system and the well-being of health care professionals, the effects of which are still felt today.

The FDA has not approved a new sunscreen ingredient since the 1990s, leaving consumers and clinicians wondering why.

Edoxaban monotherapy for patients with atrial fibrillation and stable coronary disease reduced risk for adverse clinical events, mainly driven by lower bleeding risk, compared with dual antiplatelet therapy, a speaker reported.

On this special edition episode, Shikha Jain, MD, with Physicianary’s Hansa Bhargava, MD, and Mend the Gap’s Dagny Zhu, MD, discuss the evolution of empowering yourself and others and advocacy with a panel of guests.

Although training primary care providers in shared decision-making did not significantly improve colorectal cancer concordance or screening rates in older adults, at least 5 minutes of discussion with a PCP may benefit some, data showed.

A multilevel care intervention increase advanced care planning versus clinician-level intervention alone for patients with genitourinary cancer, according to study results.

Neoadjuvant atezolizumab prior to chemoradiation therapy exhibited promising activity for patients with unresectable stage III non-small cell lung cancer, according to results of a nonrandomized phase 2 study.

Alessio Pigazzi, MD, PhD, has been appointed executive medical director of colorectal surgery at City of Hope Orange County.

A telephone-administered, positive psychology intervention improved the well-being of patients who underwent hematopoietic stem cell transplantation, according to findings published in Journal of the National Comprehensive Cancer Network.